Skip to main content
. 2017 Oct 11;7:12981. doi: 10.1038/s41598-017-12819-0

Figure 10.

Figure 10

Mutation of NCC at specific lysines influences lysosomal or proteasomal NCC degradation when expressed in MDCKI cells. (A) Representative immunoblots of NCC in lysates isolated from various MDCKI cell lines treated with vehicle (ethanol), 50 µM cycloheximide, 50 µM cycloheximide plus 20 µM MG132, 50 µM cycloheximide plus 400 µM chloroquine, 50 µM cycloheximide plus 20 µM MG132 and 400 µM chloroquine for indicated time. (B) Semi-quantitative analysis of NCC levels in various MDCKI cell lines following the different treatments. NCC levels in cells expressing K706R and K909R mutants are significantly different that WT-NCC expressing cells. Data were analyzed using two-way ANOVA followed by Tukey-Kramer multiple comparison test and presented as means ± S.E.M. (n = 6–9). *Represents significant change compared to WT-NCC under similar conditions.